Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Anticipating B117 surge, experts urge continued focus on elders, deferred 2nd vaccine doses
By
Alicia Lasek
Mar 18, 2021
Infectious disease and vaccine experts have laid out a plan for thwarting yet another uptick in transmission and illness. A new surge is likely by the end of April, they say in a CIDRAP report.
FDA: Viral mutations unlikely to cause false negatives in COVID-19 tests
By
Alicia Lasek
Jan 11, 2021
The agency has alerted healthcare providers that it is monitoring approved SARS-CoV-2 molecular tests to ensure that new viral mutations do not alter their accuracy.
Coffee tied to lower Parkinson’s risk — even in those genetically predisposed
By
Alicia Lasek
Oct 05, 2020
People who are predisposed to Parkinson’s may tend to avoid drinking coffee. Alternatively, some mutation carriers may drink a lot of coffee and benefit from its neuroprotective effects, propose investigators.
The coronavirus likely began to spread worldwide last year, say researchers
By
Alicia Lasek
May 06, 2020
The pandemic may have started as early as October 2019, quickly adapting to its human host, according to a new genetic analysis.
Stronger coronavirus mutation may be new dominant strain, say scientists
By
Alicia Lasek
May 05, 2020
A newer, more contagious coronavirus mutation has become dominant worldwide, according to investigators from Los Alamos National Laboratory.
Lung cancer mutation test approved
May 29, 2013
The U.S. Food and Drug Administration has given premarket approval to the cobas® EGFR Mutation Test from Roche Molecular Systems, creating a possible future option for metastatic lung cancer patients.
